Skip to main content
. 2020 Nov 14;2020:8890300. doi: 10.1155/2020/8890300

Table 3.

Comparison of incidence and hazard ratio of hyperlipidemia stratified by sex, age, and comorbidity between patients with and without gout.

Variable Gout Crude HR (95% CI) Adjusted HR (95% CI)
No Yes
Event PY Rate# Event PY Rate#
All 24485 1378799 17.8 13639 293172 46.5 2.61 (2.55, 2.66)∗∗∗ 2.55 (2.50, 2.61)∗∗∗
Sex
 Female 7080 282065 25.1 3217 59166 54.4 2.14 (2.06, 2.23)∗∗∗ 2.15 (2.06, 2.24)∗∗∗
 Male 17405 1096734 15.9 10422 234006 44.5 2.80 (2.73, 2.87)∗∗∗ 2.70 (2.64, 2.77)∗∗∗
Stratified age
 ≤49 10087 850974 11.9 7382 191709 40.6 3.44 (3.34, 3.55)∗∗∗ 3.08 (2.99, 3.18)∗∗∗
 50-64 9290 312176 29.8 4160 63233 65.8 2.19 (2.11, 2.27)∗∗∗ 2.18 (2.10, 2.26)∗∗∗
 65+ 5108 215649 23.7 2097 48229 43.5 1.82 (1.73, 1.91)∗∗∗ 1.88 (1.79, 1.98)∗∗∗
Comorbidity
 No 13645 1003452 13.6 10840 375347 28.9 3.40 (3.31, 3.49)∗∗∗ 3.37 (3.28, 3.46)∗∗∗
 Yes 8639 181008 47.7 5000 112164 44.6 1.57 (1.52, 1.62)∗∗∗ 1.54 (1.49, 1.60)∗∗∗

PY: person-years; Rate#: incidence rate, per 1,000 person-years; Crude HR: crude hazard ratio; Adjusted HR: multivariable analysis including age, sex, and comorbidities of hypertension, stroke, diabetes, COPD, CAD, alcohol-related illness, and asthma; Comorbidity: patients with any one of the comorbidities of hypertension, stroke, diabetes, COPD, CAD, alcohol-related illness, and asthma were classified as the comorbidity group. ∗∗∗P < 0.001.